WALTER E. STAMM, M.D.; MARY McKEVITT, R.N.; GEORGE W. COUNTS, M.D.; KENNETH F. WAGNER, D.O.; MARVIN TURCK, M.D.; KING K. HOLMES, M.D., Ph.D.
Antimicrobial prophylaxis prevents recurrent urinary tract infections in susceptible women, but its cost effectiveness has not been studied. In a recent placebo-controlled trial of urinary prophylaxis; we also assessed cost effectiveness using a decision analysis model. In our hospital the direct cost of 1 patient year of urinary prophylaxis approximates the cost of treating one episode of cystitis. In women with a baseline infection rate of three per patient year, the annual cost of prophylaxis ($85.82) was less than treatment of acute episodes of infection ($392.30). Sensitivity analyses showed that in women with three infections per year, prophylaxis became cost effective when charges per episode exceeded $42.00. In women with frequent episodes of cystitis, prophylaxis will be cost effective in most practice settings.
Learn more about subscription options.
Register Now for a free account.
STAMM WE, McKEVITT M, COUNTS GW, WAGNER KF, TURCK M, HOLMES KK. Is Antimicrobial Prophylaxis of Urinary Tract Infections Cost Effective?. Ann Intern Med. 1981;94:251–255. doi: 10.7326/0003-4819-94-2-251
Download citation file:
Published: Ann Intern Med. 1981;94(2):251-255.
Healthcare Delivery and Policy, Infectious Disease, Nephrology, Urinary Tract Infection, Urological Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only